Diligence memo · auto-generated · as of July 2, 2026

Dermasensor, Inc.

Dermasensor, Inc. looks fair against its niche peers and is quiet on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Dermasensor, Inc. operates in Other Health Care, based in Miami.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Dermasensor, Inc. has raised $29M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $8.9M on 2024-11-15.

Most recent recorded round closed around 2024-11-15.

Valuation (modeled)modeled

Provath models Dermasensor, Inc. at approximately $38M (range $11M–$75M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.02× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era. Within the normal band (102% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 24 months.

Last raise 20 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round stepped up 1.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 88% of Other Health Care peers (5377 compared).

Modeled value ranks above 63% of those peers.

Closest niche peers: CareHarmony, Inc., Dragonfly Endoscopy Inc., NuvoAir Holdings, Inc., Post Acute Recovery, Inc., Micro Interventional Devices, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.